News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
231 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21913)
Month
January (4681)
February (5218)
March (5801)
April (5233)
May (5822)
June (5224)
July (4072)
August (4645)
September (4519)
October (4153)
November (5533)
December (3823)
Day
1 (356)
2 (311)
3 (275)
4 (220)
5 (5)
6 (13)
7 (269)
8 (259)
9 (234)
10 (254)
11 (151)
12 (8)
13 (5)
14 (231)
15 (262)
16 (229)
17 (233)
18 (106)
19 (13)
20 (5)
21 (200)
22 (226)
23 (228)
24 (236)
25 (117)
26 (12)
27 (4)
28 (256)
29 (245)
30 (261)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
Deals
ICON Announces Private Offering of Senior Secured Notes
ICON plc (NASDAQ: ICLR) (“ICON”) announced today in connection with the proposed acquisition by ICON of PRA Health Sciences, Inc.
June 14, 2021
·
8 min read
Deals
Aspen Surgical Acquires Stork® Labor and Delivery Products
Aspen Surgical Products, Inc., a leader in surgical disposable products, announced the acquisition of Stork®, a division of Briggs Healthcare.
June 14, 2021
·
3 min read
FDA
Istari Oncology Announces FDA Granted Fast Track Designation to PVSRIPO for the Treatment of Advanced Melanoma
Istari Oncology, Inc. announced today the U.S. Food and Drug Administration (FDA) has granted Fast Track designation to PVSRIPO for the improved survival in patients with advanced melanoma.
June 14, 2021
·
4 min read
Business
Telix Pharmaceuticals and Applied Radiology Launch TelixU Medical Education Platform Focused on Radiopharmaceutical Research
Telix Pharmaceuticals Limited today announced the launch of TelixU , a new educational platform focused on radiopharmaceutical research in partnership with leading medical imaging journal, Applied Radiology .
June 14, 2021
·
3 min read
Biotech Bay
ReCode Therapeutics to Participate in Upcoming June Investor Conferences
ReCode Therapeutics today announced that the Company will participate in two upcoming virtual investor conferences in June.
June 14, 2021
·
1 min read
Drug Development
CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting
CorWave Successfully Performed a 90-Day In Vivo Study on Its Revolutionary Cardiac Pump Synchronized With the Native Heart, Results Presented at ASAIO Meeting.
June 14, 2021
·
3 min read
Business
Cassava Sciences Announces the Appointment of Richard J. Barry to its Board of Directors
Cassava Sciences, Inc. today announced the appointment of Mr. Richard (Rick) Barry to the Company’s Board of Directors, effective June 11, 2021.
June 14, 2021
·
5 min read
BioForest
Cocrystal’s Lead COVID-19 Antiviral CDI-45205 Shown to be Active Against SARS-CoV-2 and Two Prominent SARS-CoV-2 Variants
Cocrystal Pharma, Inc. announces that its lead preclinical SARS-CoV-2 3CL protease inhibitor CDI-45205 is active against SARS-CoV-2 and two prominent SARS-CoV-2 variants.
June 14, 2021
·
4 min read
Business
OncoSec Appoints Industry Leading Electroporation Device Expert, Jeffrey Silverman, as Vice President of Product Engineering
Mr. Silverman joins OncoSec with over two decades of electroporation device quality and manufacturing experience.
June 14, 2021
·
7 min read
Deals
AbSci Announces Acquisition of Target Discovery Company Totient
AbSci today announced the acquisition of Totient, a discovery company harnessing human immune responses to identify novel antibodies and their therapeutic targets.
June 14, 2021
·
3 min read
Previous
23 of 24
Next